Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes

被引:0
|
作者
Takigawa, Ken [1 ]
Shima, Takahiro [1 ,2 ]
Kubara, Chiaki [1 ]
Akamine, Shun [3 ]
Utsumi, Sae [1 ]
Yoshino, Teruhiko [1 ]
Minami, Mariko [1 ]
Hayashi, Masayasu [1 ]
Matsuo, Yayoi [1 ]
Kuriyama, Takuro [1 ]
Yoneda, Reiko [3 ]
Taniguchi, Shuichi [1 ]
Eto, Tetsuya [1 ]
机构
[1] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan
[2] Kyushu Univ Hosp, Dept Hematol, Fukuoka, Japan
[3] Hamanomachi Hosp, Dept Pathol, Fukuoka, Japan
关键词
autopsy; myelodysplastic syndromes; posterior reversible encephalopathy syndrome; transfusion therapy; LEUKOENCEPHALOPATHY;
D O I
10.1111/trf.17968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPosterior reversible encephalopathy syndrome (PRES) is known as a transfusion-related complication with typically favorable prognosis and no report fatalities. Pathological evaluation of PRES is also scarce.Case ReportAn 88-year-old female with myelodysplastic syndromes (MDS) attended our hospital because of a compression fracture and chronic heart failure with chronic anemia. While her hemoglobin levels improved from 4.6 to 8.0 g/dL and the pleural effusions substantially decreased following six units of red blood cell transfusion and diuretic therapy, a gradual decline in cognitive function and speech reduction was noted. PRES was diagnosed by magnetic resonance imaging of the head. Despite treatment of intensive supportive care, the patient fell into a coma by the 20th day and passed away on the 22nd day. Although the pathophysiological link between blood-transfusion-related PRES and its impact on survival is not fully understood, autopsy findings confirmed the diagnosis of PRES and revealed multiple cerebral hemorrhages that were not detected in earlier imaging studies.ConclusionThis case highlights the importance of vigilant monitoring and management of PRES, especially in high-risk populations such as elderly patients with multiple comorbidities or those with thrombocytopenia. Further studies are needed to elucidate the mechanisms of PRES in patients with hematologic diseases.
引用
收藏
页码:1791 / 1797
页数:7
相关论文
共 50 条
  • [41] Recurrent posterior reversible encephalopathy syndrome after chemotherapy in hematologic malignancy-posterior reversible encephalopathy syndrome can strike twice!!!
    Roy, Soumyajit
    Gandhi, Ajeet K.
    Jana, Manisha
    Julka, Pramod K.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (02) : 393 - 396
  • [42] Reversible posterior encephalopathy syndrome and cardiomyopathy after bevacizumab therapy
    Frantien, L.
    Rondeau-Lutz, M.
    Mosquera, F.
    Martinez, C.
    Labani, A.
    Weber, J. C.
    REVUE DE MEDECINE INTERNE, 2016, 37 (01): : 50 - 52
  • [43] Blood-transfusion-related posterior reversible encephalopathy syndrome-A description of a new case and review of the literature
    Dube, Mukesh
    Rathore, Rashi
    BRAIN CIRCULATION, 2020, 6 (04) : 269 - 273
  • [44] Posterior reversible encephalopathy syndrome after neurosurgery: A literature review
    Duran Paz, S.
    Moreno Casanova, I.
    Benatar-Haserfaty, J.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2015, 62 (10): : 585 - 589
  • [45] Posterior reversible encephalopathy syndrome: A rare neurotoxicity after capecitabine
    Monti, Manlio
    Barone, Domenico
    Amadori, Elena
    Bartolini, Giulia
    Ruscelli, Silvia
    Frassineti, Giovanni Luca
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (07) : 1795 - 1801
  • [46] Delayed posterior reversible encephalopathy syndrome (PRES) after posterior fossa surgery
    J. M. Avecillas-Chasín
    G. Gómez
    M. Jorquera
    L. R. Alvarado
    J. A. Barcia
    Acta Neurochirurgica, 2013, 155 : 1045 - 1047
  • [47] Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus after cessation of oral prednisone
    Li, Qi
    Lv, Fajin
    Wei, Youdong
    Yan, Bernard
    Xie, Peng
    NEUROLOGICAL SCIENCES, 2013, 34 (12) : 2241 - 2242
  • [48] Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus after cessation of oral prednisone
    Qi Li
    Fajin Lv
    Youdong Wei
    Bernard Yan
    Peng Xie
    Neurological Sciences, 2013, 34 : 2241 - 2242
  • [49] Basiliximab for posterior reversible encephalopathy syndrome after lung transplantation
    Yamagishi, Hiroya
    Chen-Yoshikawa, Toyofumi F.
    Date, Hiroshi
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2017, 52 (04) : 823 - 824
  • [50] Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen
    Plavetic, Natalija Dedic
    Rakusic, Zoran
    Ozretic, David
    Simetic, Luka
    Krpan, Ana Misir
    Bisof, Vesna
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12